跳至主要内容
临床试验/ISRCTN15109717
ISRCTN15109717进行中(未招募)3 期

Sugammadex for prevention of postoperative pulmonary complications

Belfast Health and Social Care Trust0 个研究点目标入组 2,500 人开始时间: 2022年12月21日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
2,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients presenting for elective or emergency major abdominal or non-cardiac thoracic surgery
  • 2. Age =50 years
  • 3. Planned use of rocuronium or vecuronium for neuromuscular blockade
  • 4. Planned reversal of neuromuscular blockade at the end of surgery

排除标准

  • 1. Known allergy to sugammadex, neostigmine or glycopyrrolate
  • 2. Lack of written informed consent for trial participation
  • 3. Planned invasive mechanical ventilation before or after surgery
  • 4. Previous participation in SINFONIA trial
  • 5. Clinician refusal (with reason)

研究者

相似试验

Sugammadex for prevention of postoperative pulmonary... | 临床试验